Holen Sie sich die Stockscreener-App
1.38
2.22%
0.03
Vorhandelsmarkt:
1.41
0.03
+2.17%
Schlusskurs vom Vortag:
$1.35
Offen:
$1.41
24-Stunden-Volumen:
1.98M
Relative Volume:
3.09
Marktkapitalisierung:
$51.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.94M
KGV:
-1.00
EPS:
-1.38
Netto-Cashflow:
$-15.79M
1W Leistung:
+23.21%
1M Leistung:
+20.00%
6M Leistung:
-23.33%
1J Leistung:
-36.11%
1-Tages-Spanne:
$1.30
$1.47
1-Wochen-Bereich:
$1.08
$1.47
52-Wochen-Spanne:
$0.87
$2.74
MAIA Biotechnology Inc Stock (MAIA) Company Profile
Firmenname
MAIA Biotechnology Inc
Sektor
Branche
Telefon
312 416 8592
Adresse
444 West Lake Street, Suite 1700, Chicago
Vergleichen Sie MAIA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.38 | 49.99M | 0 | -25.94M | -15.79M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten
MAIA Biotechnology Advances NSCLC Treatment with Ateganosine - TipRanks
MAIA Biotechnology, Inc. Targets $50B Immunotherapy Market with New Approach - TradingView
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach - GlobeNewswire
Prepare Yourself for Liftoff: MAIA Biotechnology Inc (MAIA) - Setenews
Director Makes Bold Move with Major Stock Purchase in MAIA Biotechnology! - TipRanks
Can MAIA Biotechnology Inc. stock sustain revenue momentum2025 Price Targets & Real-Time Price Movement Reports - Newser
How MAIA Biotechnology Inc. stock reacts to bond yieldsWeekly Gains Summary & Free Technical Pattern Based Buy Signals - Newser
Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock By Investing.com - Investing.com Australia
Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock - Investing.com
Is MAIA Biotechnology Inc. stock among top earnings plays2025 Stock Rankings & Daily Chart Pattern Signals - Newser
How MAIA Biotechnology Inc. stock compares with top peersMarket Trend Summary & Fast Gain Swing Alerts - Newser
Why hedge funds are buying MAIA Biotechnology Inc. stockRisk Management & Daily Risk Controlled Trade Plans - Newser
MAIA Biotechnology Inc (MAIA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
How MAIA Biotechnology Inc. stock responds to policy changesTrade Analysis Report & Daily Risk Controlled Trade Plans - Newser
Will MAIA Biotechnology Inc. stock return to pre crash levels2025 Bull vs Bear & Smart Allocation Stock Reports - Newser
How MAIA Biotechnology Inc. stock compares with market leaders2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Will MAIA Biotechnology Inc. stock recover faster than industryAnalyst Upgrade & Safe Entry Zone Tips - Newser
Why MAIA Biotechnology Inc. stock could rally stronglyJuly 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - Newser
Top Executives Make Bold Moves with Major Stock Purchases at MAIA Biotechnology! - TipRanks
Maia Biotechnology announces open market purchases by CEO and directors - marketscreener.com
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors - The Manila Times
MAIA Biotechnology (NYSE American: MAIA) execs buy 182,445 shares, 38% response - Stock Titan
Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848 By Investing.com - Investing.com Australia
Luput Cristian, director at Maia Biotechnology, buys $41,845 in shares By Investing.com - Investing.com South Africa
Smith Stan, MAIA Biotechnology director, buys $15,582 in shares By Investing.com - Investing.com South Africa
Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848 - Investing.com India
Smith Stan, MAIA Biotechnology director, buys $15,582 in shares - Investing.com
MAIA Biotechnology Executives Increase Holdings - TradingView
Luput Cristian, director at Maia Biotechnology, buys $41,845 in shares - Investing.com
MAIA Biotechnology Inc Stock Analysis and ForecastMACD Histogram Signals & Affordable Market Trading - earlytimes.in
CEO’s Bold Move: Major Stock Purchase at MAIA Biotechnology! - TipRanks
Luput Cristian, director at Maia Biotechnology, buys $9,785 in shares By Investing.com - Investing.com Australia
Maia Biotech CEO Vitoc Vlad buys $10k in company stock - Investing.com Canada
Maia Biotech CEO Vitoc Vlad buys $10k in company stock By Investing.com - Investing.com South Africa
Luput Cristian, director at Maia Biotechnology, buys $9,785 in shares - Investing.com
Finanzdaten der MAIA Biotechnology Inc-Aktie (MAIA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
Kapitalisierung:
|
Volumen (24h):